Suggested Topics within your search.
Suggested Topics within your search.
- English language 55
- Rhetoric 41
- History 31
- Report writing 30
- Management 25
- Grammar 23
- methods 22
- Law 21
- Moral and ethical aspects 18
- Research 18
- College readers 16
- Human anatomy 14
- Philosophy 13
- Handbooks, manuals, etc 12
- Methodology 12
- Problems, exercises, etc 12
- Social conditions 12
- Study and teaching 12
- Politics and government 11
- Academic writing 10
- Leadership 10
- Nursing 10
- Biochemistry 9
- Calculus 9
- Economic development 9
- Human physiology 9
- Mathematics 9
- Policy sciences 9
- Social aspects 9
- Anatomy 8
-
11641
-
11642
Ethnobotanical survey of medicinal and aromatic plants used by the population of Settat Province, Morocco
Published 2025-02-01Get full text
Article -
11643
-
11644
-
11645
-
11646
-
11647
National Thalassemia Registry: a 30 year journey of implementing carrier screening in Singapore
Published 2025-02-01Get full text
Article -
11648
-
11649
-
11650
GEPREP: A comprehensive data atlas of RNA-seq-based gene expression profiles of exercise responses
Published 2025-12-01Get full text
Article -
11651
-
11652
-
11653
-
11654
-
11655
-
11656
-
11657
Impact of HVDC link and electric vehicle on multi-area power system using MOA optimized I-TD2N controller
Published 2025-03-01Get full text
Article -
11658
The transport of polyphenols from Camellia fascicularis in Caco-2 cells based on UPLC-ESI-MS/MS
Published 2025-01-01Get full text
Article -
11659
Safety and efficacy of the amino acid-crosslinked hyaluronic acid in the treatment of temple hollowing
Published 2025-02-01“…Background: Loss of volume in the temples is an early sign of aging and often gives the impression of a gaunt and emaciated appearance. Objective: The authors conduct a clinical study to investigate the safety and effectiveness of the amino acid crosslinked hyaluronic acid (ACHA) for the treatment of temple hollowing. …”
Get full text
Article -
11660
Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
Published 2025-02-01“…Background: Recombinant zoster vaccine (RZV), received its first marketing authorization in October 2017 to prevent herpes zoster and its complications in older adults. …”
Get full text
Article